CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Melissa A. Jackson

OPENALEX: A5041922161↗ORCID: 0000-0002-1491-6218↗

Affiliations

Organizations

Hunter New England Local Health Districtauthorship · AU Sydney Local Health Districtauthorship · AU University of Newcastle Australiaauthorship · AU

Public evidence

2 connected articles

The use and effects of synthetic cannabinoid receptor agonists by New South Wales cannabis treatment clients.2021 · Europe PMC Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.2018 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Melissa A. Jackson - Medical Cannabis Research Engine